• Federal Circuit Holds Claims Indefinite Based on Prosecution History in Teva Pharmaceuticals USA v. Sandoz, Inc.
  • July 13, 2015 | Authors: Shawn P. Gorman; R. Gregory Israelsen
  • Law Firms: Banner & Witcoff, Ltd. - Chicago Office ; Banner & Witcoff, Ltd. - Washington Office
  • On June 18, 2015, the United States Court of Appeals for the Federal Circuit released its decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.i The case was on remand from the Supreme Court, which vacated the Federal Circuit’s earlier determination regarding the definiteness of claims directed towards Copaxone®, Teva’s market-approved treatment for multiple sclerosis.ii